🇪🇺 Jenzyl in European Union

EMA authorised Jenzyl on 14 December 2012

Marketing authorisation

EMA — authorised 14 December 2012

  • Application: EMEA/H/C/002259
  • Marketing authorisation holder: Merck Sharp and Dohme Ltd.
  • Local brand name: Jenzyl
  • Indication: TReament of metastatic soft tissue sarcoma or bone sarcoma
  • Status: withdrawn

Read official source →

Other Other approved in European Union

Frequently asked questions

Is Jenzyl approved in European Union?

Yes. EMA authorised it on 14 December 2012.

Who is the marketing authorisation holder for Jenzyl in European Union?

Merck Sharp and Dohme Ltd. holds the EU marketing authorisation.